Clinical Trials Browser

Interventional × Lymphoproliferative Disorders × phenethyl isothiocyanate × Clear all

NCT00968461 2013-04-15

Study of Phenethyl Isothiocyanate in Lymphoproliferative Disorders

Phase 1 Withdrawn

LymphoidOther hematologic neoplasm

Leukemia, Lymphoproliferative Disorders, Leukemia, Lymphocytic, Chronic, B-Cell